Quimdis, european distributor of raw materials and active ingredients for the pharmaceutical, nutraceutical, food, cosmetic and aromatic industries for over 30 years, has decided to rely on the Azelis group to pursue its development as of 1 September 2021.
Founded in 1988, Quimdis has sales in 45 countries, a turnover of almost €100 million and supplies more than 1,000 customers with a portfolio of around 400 suppliers.
This transaction gives Quimdis the opportunity to expand its international sales network and to benefit from Azelis’ expertise and technical capabilities in order to develop and promote innovative and sustainable solutions in its various business sectors.
The acquisition of Quimdis provides Azelis in EMEA with an important foothold in the growing non-cyclical markets of flavors and fragrances, synergistic opportunities in animal nutrition, and expands its offering in nutraceuticals.
Quimdis will pursue its activities in the continuity of the past years without any change in its way of working or in its relations with its customers and suppliers.
Mr. Jean-François Quarré, Founder and CEO at Quimdis, comments:
“We are delighted about the opportunity to
continue to grow our business under Azelis’ ownership. As well as
benefitting from Azelis’ global principal relationships, Quimdis will
have access to Azelis’ digital marketing and technical capabilities
which will allow us to develop and promote innovative and sustainable
solutions for the life science industry. Becoming part of the Azelis
family provides many synergistic opportunities that will help secure our
future.“
Mr. Benoit Fritz, Managing Director of Azelis France, adds:
“Azelis will leverage Quimdis’ expertise to
complement our lateral value chain with reliable and natural products
like essential oils, amino acids, active ingredients, vitamins and
minerals. We will further benefit from their strong presence across
EMEA, expertise and product portfolio in attractive target market
segments and geographies“